How Samsung Bioepis Is Laying A Path For Ophthalmic Biosimilars

Strategy Head Josh Lee Also Emphasizes Need For Biosimilar Education And Incentives

 
• By David Wallace
  
Josh Lee, Samsung Bioepis
Josh Lee talks about how Samsung Bioepis is preparing to break into the ophthalmology market • Source: Samsung Bioepis
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products